Tag: economist Alex Tabarrok
The Simple Anti-COVID Measures We’re Not Taking
This is an edition of Up for Debate, a newsletter by Conor Friedersdorf. On Wednesdays, he rounds up timely conversations and solicits reader responses to one thought-provoking question. Soon after, he publishes some thoughtful replies. Sign up for the newsletter here.
Question of the Week
Say you received $1 billion to spend on improving the world. How would you spend it? Why?
Email your thoughts to [email protected]. I’ll publish a selection of correspondence in an upcoming newsletter.
Conversations of
FDA Delays Carry a Death Toll
This morning, the FDA granted full approval to the Pfizer vaccine for use in people 16 and older. Although “the vaccine approval was the fastest in the agency’s history,” as The Washington Post noted, serious side effects have proved extremely rare. Nevertheless, anti-vaccine activists—and the politicians and pundits pandering to them—have criticized the accelerated approval process as rushed. Yet the problem with the FDA is precisely the opposite: The agency too often fails to recognize the danger of being